Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Hutson Nancy J
Relationship:   Director
City:   Durham
State:   NC
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   212,328    

Indirect Shares

  5,000      
Direct Value   $568,120    

Indirect Value

  $1      
Total Shares   217,328      
Total Value   $568,121      


Biocryst Pharmaceuticals Inc
 $409,090 Phasebio Pharmaceuticals Inc
 $0 Clearside Biomedical, Inc.
 $159,030 Biocryst Pharmaceuticals Inc
 $409,090 Phasebio Pharmaceuticals Inc
 $0 Clearside Biomedical, Inc.
 $159,030
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    6   
    1    

     Stock price went up :

    3   
    0    
     Stock price went down :
    3   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   17.5%
 -30.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Endo Health Solutions Inc ENDP Director 2014-02-28 0 2010-12-07 1,000    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-14 81,818 0    Premium*  
            Phasebio Pharmaceuticals Inc PHAS Director 2023-05-19 37,510 2023-05-19 4,000    Premium*  
            Clearside Biomedical, Inc. CLSD Director 2023-10-03 93,000 2020-05-20 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CLSD Clearside Biomedical, Inc... Director   –       •      –    2023-10-03 4 B $0.86 $8,600 D/D 10,000 93,000 2.39 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2023-06-14 4 S $8.04 $103,443 D/D (12,866) 81,818 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 16,745 94,684 0 -
PHAS Phasebio Pharmaceuticals ... Director   –       •      –    2023-05-19 4 OE $0.00 $0 D/D 3,750 37,510 0 -
CLSD Clearside Biomedical, Inc... Director   –       •      –    2022-11-17 4 B $1.33 $39,900 D/D 30,000 83,000 2.39 %
PHAS Phasebio Pharmaceuticals ... Director   –       •      –    2021-11-08 4 OE $3.15 $23,310 D/D 7,400 33,760 0 -
PHAS Phasebio Pharmaceuticals ... Director   –       •      –    2021-11-05 4 OE $2.26 $60,909 D/D 26,360 26,360 0 -
CLSD Clearside Biomedical, Inc... Director   –       •      –    2021-10-29 4 OE $2.00 $81,350 D/D 40,000 53,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-10-15 4 OE $1.71 $363,450 D/D 105,000 170,073 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-10-15 4 AS $15.40 $1,617,000 D/D (105,000) 65,073 0 %
PHAS Phasebio Pharmaceuticals ... Director   –       •      –    2021-08-18 4 B $3.08 $9,240 I/I 3,000 4,000 2.1 -
CLSD Clearside Biomedical, Inc... Director   –       •      –    2021-08-16 4 B $5.68 $17,040 D/D 3,000 13,000 2.39 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-06-10 4 AS $16.86 $393,394 D/D (23,333) 65,073 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-06-10 4 OE $2.85 $73,549 D/D 23,333 88,406 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-28 4 A $15.77 $4,999 D/D 317 65,073 0 -
CLSD Clearside Biomedical, Inc... Director   –       •      –    2021-03-12 4 B $3.11 $15,525 D/D 5,000 10,000 2.39 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-02-26 4 A $10.78 $4,991 D/D 463 64,756 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-11-30 4 A $5.11 $4,998 D/D 978 64,293 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-08-31 4 A $4.15 $4,997 D/D 1,204 63,315 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-06-01 4 A $4.50 $9,997 D/D 2,224 62,111 0 -
CLSD Clearside Biomedical, Inc... Director   –       •      –    2020-05-20 4 B $1.85 $9,250 D/D 5,000 5,000 2.39 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-03-01 4 A $3.00 $9,999 D/D 3,333 59,887 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-12-01 4 A $2.85 $9,998 D/D 3,508 56,554 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-11-18 4 B $1.45 $14,500 D/D 10,000 53,046 2.39 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-09-01 4 A $2.99 $9,999 D/D 3,344 43,046 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed